Bryant Dronette
Psychiatric/Mental Health · Lafayette, LANPI 1780088526
Payments from drug & device makers
Across 992 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$812
- plus $8K from 26 others
What the payments were for
- Food & beverage$16,56299%
- Education$2441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 137 | $1,952 |
| Teva Pharmaceuticals USA, Inc. | 87 | $1,923 |
| Alkermes, Inc. | 110 | $1,589 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 85 | $1,111 |
| Johnson & Johnson(2 entities) | 54 | $1,056 |
| Neurocrine Biosciences, Inc. | 55 | $812 |
| Sunovion Pharmaceuticals Inc. | 73 | $744 |
| Otsuka America Pharmaceutical, Inc. | 37 | $740 |
| Vanda Pharmaceuticals Inc. | 31 | $730 |
| Noven Therapeutics, LLC | 49 | $699 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $670 |
| Braeburn Inc. | 31 | $662 |
| Corium, LLC | 37 | $643 |
| Harmony Biosciences LLC | 15 | $616 |
| Tris Pharma Inc | 36 | $581 |
| Axsome Therapeutics, Inc. | 22 | $533 |
| Indivior Inc. | 13 | $268 |
| Idorsia Pharmaceuticals US Inc | 11 | $239 |
| E.r. Squibb & Sons, L.L.C. | 12 | $228 |
| Almatica Pharma LLC | 9 | $222 |
| Supernus Pharmaceuticals, Inc. | 12 | $220 |
| Ironshore Pharmaceuticals Inc. | 7 | $125 |
| Lundbeck LLC | 4 | $90 |
| Eisai Inc. | 4 | $69 |
| Bausch Health US, LLC | 4 | $65 |
| Jazz Pharmaceuticals Inc. | 3 | $60 |
| Avanir Pharmaceuticals, Inc. | 3 | $59 |
| Neos Therapeutics, LP | 2 | $29 |
| Noven Pharmaceuticals, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$487
- VRAYLAR$132
- Austedo XR$122
- QUVIVIQ$108
- Auvelity$104
- Dyanavel XR$103
- Quillivant$103
- Quillichew ER$103
How this compares
$16,807 in reported general payments places this provider in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 60 | $373,815 |
| IngrezzaValbenazine Tosylate | 33 | $258,761 |
| RexultiBrexpiprazole | 143 | $241,688 |
| VraylarCariprazine Hcl | 142 | $217,209 |
| CaplytaLumateperone Tosylate | 60 | $108,580 |
| LybalviOlanzapine/Samidorphan Malate | 33 | $57,311 |
| Invega SustennaPaliperidone Palmitate | 11 | $36,249 |
| VyvanseLisdexamfetamine Dimesylate | 61 | $23,529 |
| TrintellixVortioxetine Hydrobromide | 43 | $22,724 |
| Lisdexamfetamine Dimesylate | 55 | $13,251 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 352 | $12,292 |
| AuvelityDextromethorphan Hbr/Bupropion | 13 | $11,480 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $9,992 |
| FetzimaLevomilnacipran Hcl | 16 | $9,114 |
| Lurasidone Hcl | 101 | $7,375 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,923 | $373,81560 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $812 | $258,76133 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $740 | $241,688143 claims |
| AbbVieVraylar, Fetzima | $1,952 | $226,323158 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,111 | $108,58060 claims |
| Alkermes, Inc.Lybalvi | $1,589 | $57,31133 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $670 | $46,252104 claims |
| Johnson & JohnsonInvega Sustenna | $1,056 | $36,24911 claims |
| Axsome Therapeutics, Inc.Auvelity | $533 | $11,48013 claims |
| Indivior Inc.Suboxone | $268 | $9,99212 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $239 | $5,62812 claims |
| Corium, LLCAzstarys | $643 | $5,49914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Lafayette
- Melissa GuilbeauLafayette$122K
- Cinderella BroussardLafayette$14K
- Lore Lyndsey MoranLafayette$12K
- Danielle ThreattsLafayette$11K
- Seth WoodruffLafayette$10K
- Latonya WoodsLafayette$10K
- Laura KightLafayette$9K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.